Huanglian-Jie-Du-Tang extract protects against chronic brain injury after focal cerebral ischemia via hypoxia-inducible-factor-1α-regulated vascular endothelial growth factor signaling in mice

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 3, 2012, Pages 355-361

  Ye, Yilu ^a   Huang, Chunyan ^a,b   Jiang, Lili ^a,b   Shen, Xiangdi ^a   Zhu, Shanyong ^a   Rao, Yan ^a   Wang, Jue ^a   Zhang, Qi ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Aqueous extract; Cerebral ischemia; Ethanolic extract; Mouse

Indexed keywords

CD31 ANTIGEN; HUANGLIAN JIE DU TANG; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CELL COUNT; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MECHANISM; MALE; MOUSE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOLVENT EXTRACTION; SURVIVAL RATE;

ANIMALS; ANTIGENS, CD31; BRAIN INJURY, CHRONIC; BRAIN ISCHEMIA; COMPLEX MIXTURES; DRUGS, CHINESE HERBAL; ETHANOL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; NEUROPROTECTIVE AGENTS; PSYCHOMOTOR PERFORMANCE; SIGNAL TRANSDUCTION; SOLVENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; WATER;

EID: 84863273242     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.355     Document Type: Article

References (43)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, Mcdermott M, Meigs J, Moy C, Nichol G, O'donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics - update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation, 117, 25-146 (2008).
2. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci., 26, 248-254 (2003).
3. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab., 24, 133-150 (2004).
4. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke, 25, 1794-1798 (1994).
5. Ohta Y, Kongo-Nishimura M, Hayashi T, Kishikawa T. Effect of oren-gedoku-to (huanglian-jie-du-tang) extract on disruption of hepatic antioxidant defense systems in rats treated with D-galactosamine. J. Ethnopharmacol., 94, 323-329 (2004).
6. Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT, Lin CC. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. J. Gastroenterol. Hepatol., 23, 290-299 (2008).
7. Ohta Y, Kobayashi T, Nishida K, Sasaki E, Ishiguro I. Preventive effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on the development of stress-induced acute gastric mucosal lesions in rats. J. Ethnopharmacol., 67, 377-384 (1999).
8. Wang LM, Yamamoto T, Wang XX, Yang L, Koike Y, Shiba K, Mineshita S. Effects of oren-gedoku-to and unsei-in, Chinese traditional medicines, on interleukin-8 and superoxide dismutase in rats. J. Pharm. Pharmacol., 49, 102-104 (1997).
9. Zeng H, Liu X, Dou S, Xu W, Li N, Liu X, Zhang W, Hu Z, Liu R. Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway. J. Pharm. Pharmacol., 61, 1699-1707 (2009).
10. Sekiya N, Kainuma M, Hikiami H, Nakagawa T, Kouta K, Shibahara N, Shimada Y, Terasawa K. Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits. Biol. Pharm. Bull., 28, 294-298 (2005).
11. Ma Z, Otsuyama K, Liu S, Abroun S, Ishikawa H, Tsuyama N, Obata M, Li FJ, Zheng X, Maki Y, Miyamoto K, Kawano MM. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood, 105, 3312-3318 (2005).
12. Kabuto H, Asanuma M, Nishibayashi S, Iida M, Ogawa N. Chronic administration of Oren-gedoku-to (TJ15) inhibits ischemia-induced changes in brain indoleamine metabolism and muscarinic receptor binding in the Mongolian gerbil. Neurochem. Res., 22, 33-36 (1997).
13. Xu J, Murakami Y, Matsumoto K, Tohda M, Watanabe H, Zhang S, Yu Q, Shen J. Protective effect of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) against impairment of learning and memory induced by transient cerebral ischemia in mice. J. Ethnopharmacol., 73, 405-413 (2000).
14. Kondo Y, Kondo F, Asanuma M, Tanaka K, Ogawa N. Protective effect of oren-gedoku-to against induction of neuronal death by transient cerebral ischemia in the C57BL/6 mouse. Neurochem. Res., 25, 205-209 (2000).
15. Hwang YS, Shin CY, Huh Y, Ryu JH. Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats. Life Sci., 71, 2105-2117 (2002).
16. Zhang Q, Ye YL, Yan YX, Zhang WP, Chu LS, Wei EQ, Yu YP. Protective effects of Huanglian-Jie-Du-Tang on chronic brain injury after focal cerebral ischemia in mice. Zhejiang Da Xue Xue Bao Yi Xue Ban, 38, 75-80 (2009).
17. Li X, Li C, Ji X, Song Z, Wang L, Zhang J, Zhang Y. Huang-Lian-Jie-Du- Tang inhibits myocardial remodeling in a rat model of metabolic syndrome. J. Ethnopharmacol., 119, 259-265 (2008).
18. Shen ZB, Yin YQ, Tang CP, Yan CY, Chen C, Guo LB. Pharmacodynamic screening and simulation study of anti-hypoxia active fraction of xiangdan injection. J. Ethnopharmacol., 127, 103-107 (2010).
19. Hwang KY, Oh YT, Yoon H, Lee J, Kim H, Choe W, Kang I. Baicalein suppresses hypoxia-induced HIF-1alpha protein accumulation and activation through inhibition of reactive oxygen species and PI 3-kinase/Akt pathway in BV2 murine microglial cells. Neurosci. Lett., 444, 264-269 (2008).
20. Zhou XQ, Zeng XN, Kong H, Sun XL. Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci. Lett., 447, 31-36 (2008).
21. Zhang ZJ, Li P, Wang Z, Li PT, Zhang WS, Sun ZH, Zhang XJ, Wang YY. A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. Brain Res., 1123, 188-195 (2006).
22. Mao Y, Yang GY, Zhou LF, Stern JD, Betz AL. Focal cerebral ischemia in the mouse: description of a model and effects of permanent and temporary occlusion. Brain Res. Mol. Brain Res., 63, 366-370 (1999).
23. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke, 17, 472-476 (1986).
24. Yonemori F, Yamaguchi T, Yamada H, Tamura A. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab., 18, 1099-1106 (1998).
25. Gibson CL, Murphy SP. Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J. Cereb. Blood Flow Metab., 24, 805-813 (2004).
26. Ho WK, Wen HL, Lee CM. Tetramethylpyrazine for treatment of experimentally induced stroke in Mongolian gerbils. Stroke, 20, 96-99 (1989).
27. Ye YL, Shi WZ, Zhang WP, Wang ML, Zhou Y, Fang SH, Liu LY, Zhang Q, Yu YP, Wei EQ. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries. Eur. J. Pharmacol., 557, 23-31 (2007).
28. Dyker AG, Lees KR. Duration of neuroprotective treatment for ischemic stroke. Stroke, 29, 535-542 (1998).
29. Cheng YD, Al-Khoury L, Zivin JA. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx, 1, 36-45 (2004).
30. Chavez A, Miranda LF, Pichiule P, Chavez JC. Mitochondria and hypoxia-induced gene expression mediated by hypoxia-inducible factors. Ann. N. Y. Acad. Sci., 1147, 312-320 (2008).
31. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med., 182, 1683-1693 (1995).
32. Shyu WC, Lin SZ, Chiang MF, Su CY, Li H. Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J. Neurosci., 26, 3444-3453 (2006).
33. Crasta JA, Mishra S, Vallikad E. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression. Int. J. Gynecol. Pathol., 30, 521-526 (2011).
34. Spencer M, Unal R, Zhu B, Rasouli N, McGehee RE Jr, Peterson CA, Kern PA. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J. Clin. Endocrinol. Metab., 96, e1990-e1998 (2011).
35. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev., 25, 581-611 (2004).
36. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest., 111, 1843-1851 (2003).
37. Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature, 438, 954-959 (2005).
38. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest., 106, 829-838 (2000).
39. Harms KM, Li L, Cunningham LA. Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling. PLoS ONE, 5, e9767 (2010).
40. Roitbak T, Li L, Cunningham LA. Neural stem/progenitor cells promote endothelial cell morphogenesis and protect endothelial cells against ischemia via HIF-1alpha-regulated VEGF signaling. J. Cereb. Blood Flow Metab., 28, 1530-1542 (2008).
41. Mu D, Jiang X, Sheldon RA, Fox CK, Hamrick SE, Vexler ZS, Ferriero DM. Regulation of hypoxia-inducible factor 1α and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol. Dis., 14, 524-534 (2003).
42. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol., 156, 965-976 (2000).
43. Choi DY, Baek YH, Huh JE, Ko JM, Woo H, Lee JD, Park DS. Stimulatory effect of cinnamomum cassia and cinnamic acid on angiogenesis through up-regulation of VEGF and Flk-1/KDR expression. Int. Immunopharmacol., 9, 959-967 (2009).